Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic efficiency and safety assessment of Centella asiatica capsule in patients with non-alcoholic steatohepatitis (NASH) in Thailand
TCTR20221215002Phase 3Unknown
- Sponsor
- (in process) the Royal College of Physicians of Thailand
- Start
- Dec 2022
- Countries
- 1
01
Overview
A Phase 3 trial of centella asiatica in metabolic dysfunction-associated steatohepatitis (MASH), sponsored by (in process) the Royal College of Physicians of Thailand. Status: unknown.
02
Drugs
centella asiatica
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on TCTR20221215002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221215002.